Detalhe da pesquisa
1.
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Proc Natl Acad Sci U S A
; 109(49): 20101-6, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169655